Meningococcal vaccine
Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers
13
Recommendations for Serogroup B Meningococcal Vaccine for Persons 10 Years and Older
9
Henoch-Schonlein Purpura Following a Meningococcal Vaccine
6
Henoch-Schönlein Purpura and Polysaccharide Meningococcal Vaccine
7
Adoption of Serogroup B Meningococcal Vaccine Recommendations
12
Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine
10
Impact of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer blind, phase 3 randomised clinical trial
31
Understanding the Category B Recommendation for Serogroup B Meningococcal Vaccine
5
Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine
6
Immunogenicity of MenACWY CRM in Korean Military Recruits: Influence of Tetanus Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY CRM
6
Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine
9
Critical appraisal of a quadrivalent CRM<sub>197</sub> conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo<sup>®</sup>) in the context of treatment and prevention of invasive disease
11
Carriage rates of Neisseria meningitides serogroups: determination among freshmen conscripts before vaccination
7
Effectiveness and Duration of Protection of One Dose of a Meningococcal Conjugate Vaccine
10
Harberger_unc_0153D_17600.pdf
96
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
15
Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FCγ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth
7
Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years
10
UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
10
Epidemiological Status of Bacterial Meningitis Disease Following the Introduction of the Meningococcal A Conjugate Vaccine in the African Meningitis Belt
11